Position in HALO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$15,054,912
-$542,401 QoQ
Shares Held
232,940
+0.5% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
2.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026South Street Advisors LLC holds $32,379,812 across 2 Biotechnology names. HALO ranks #2 (46.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
403,938 | $17,324,900 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
232,940 | $15,054,912 |
All Filings in HALO
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,054,912 | 232,940 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $15,597,313 | 231,758 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $18,177,465 | 247,852 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,550,761 | 241,268 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $15,544,754 | 243,610 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,985,064 | 229,765 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,811,794 | 171,415 | Shares | Sole | 2024-11-06 | |
| No filing history on record for this holder in this stock. | ||||||